← All trials
NCT01199562
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2010
- Primary completion
- Dec 1, 2013
- Completion date
- Dec 1, 2013
- First posted
- —
- Last posted
- —
- Enrollment
- 153
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- City of Hope National Medical CenterLead sponsor
- National Cancer Institute (NCI)Collaborator
- City of Hope National Medical CenterOverall official - principal investigator
Drugs studied
Indications studied
- Immunoglobulin Light-chain Amyloidosis
- Anemia, Aplastic
- Burkitt Lymphoma
- Cytomegalovirus Infections
- Hodgkin Disease
- Leukemia
- Leukemia, Hairy Cell
- Leukemia, Mast-Cell
- Lymphoma
- Lymphoma, Follicular
- Lymphoma, Non-Hodgkin
- Lymphomatoid Granulomatosis
- Waldenstrom Macroglobulinemia
- Multiple Myeloma
- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- Plasmacytoma
- Polycythemia Vera
- Sezary Syndrome
- Thrombocythemia, Essential
- Transplantation
- Leukemia, Lymphocytic, Chronic, B-Cell
- Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
- Leukemia-Lymphoma, Adult T-Cell
- Leukemia, Prolymphocytic
- Leukemia, Myeloid, Chronic-Phase
- Leukemia, Neutrophilic, Chronic
- Leukemia, Myeloid, Acute
- Leukemia, Eosinophilic, Acute
- Leukemia, Myelomonocytic, Chronic
- Lymphoma, T-Cell
- Lymphoma, Large-Cell, Immunoblastic
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Large-Cell, Anaplastic
- Lymphoma, B-Cell, Marginal Zone
- Lymphoma, Mantle-Cell
- Leukemia, Large Granular Lymphocytic
- Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
- Lymphoma, Primary Cutaneous Anaplastic Large Cell
- Primary Myelofibrosis
- Intraocular Lymphoma
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.